DIOSNA presents a compact, closed granulation line in "Rapid Change" design. It is a complete system for mixing, granulating and drying of pharmaceutical products in the field of R&D and clinical samples.
DIOSNA presents a compact, closed granulation line in "Rapid Change" design.
It is a complete system for mixing, granulating and drying of pharmaceutical products in the field of R&D and clinical samples.
Interchangeable product containers of different sizes from 10l to 80l are available. The system can be designed for containment applications. All current PAT systems can be integrated. A stainless steel wall in which the HMI is implemented, builds the border to the technical area. This improves the accessibility of technical components for maintenance and reduces cleanroom space.
The exhibit can be seen at the Interpack (Düsseldorf) Hall 3/E01.
Contact: Markus Nowak, Product Manager, Pharma Systems
e-mail markus.nowak@diosna.de
+49 (0)541 33104-814
Diosna Dierks & Söhne GmbH
Am Tie 23
49086 Osnabrűck
www.diosna.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Adding SYLOID® Mesoporous Silica to Improve Run Time and Yield for Micronization Processes
May 9th 2025A must-read for anyone in the industry looking to enhance their micronization processes. Discover how adding low percentages of SYLOID® mesoporous silica can significantly improve the run time and yield of jet milling processes for hard-to-process Active Pharmaceutical Ingredients (APIs). Imagine achieving a more consistent feed rate and a homogenous final product simply by pre-blending SYLOID® mesoporous silica with your APIs. Grace & Microsize conducted experiments that reveal substantial improvements in both run time and yield, making this paper an essential guide for professionals aiming to optimize their manufacturing processes and boost efficiency and feed rate consistency.